OWINGS MILLS, Md., July 22 /PRNewswire-FirstCall/ -- The Chairman of the Board of Directors of Medifast, Inc. (NYSE: MED), our Directors, Employees and Associates are delighted that one of our Medifast Independent Directors, Lt. Gen. Dennis McCarthy (Ret) has been nominated by President Obama, and confirmed by the U.S. Senate, as the new Assistant Secretary of Defense for Reserve Affairs.
Gen. McCarthy has served his country in the United States Marine Corps for over 36 years and most recently was the Executive Director of the Reserve Officers Association of the United States.
"Medifast's Board of Directors applauds this appointment of a great American and a dedicated public servant," said Bradley T. MacDonald, Executive Chairman of the Board, Medifast, Inc. "Gen. McCarthy has served on the Board of Medifast since 2006 and has made remarkable contributions to the growth and profitability of Medifast. His insights into the marketplace of today's consumers were invaluable and his detailed understanding of Commercial Law and Ethics has served the shareholders of Medifast well."
Due to his appointment, Gen McCarthy must resign from the Board of Medifast effective the day of his confirmation by the U.S. Senate. The Board of Directors is delighted that he is serving our Nation in such an important position protecting our nation with our citizen Soldiers, Sailors, Airmen and Marines and we want to commend Gen. McCarthy for his service to the Company.
Medifast Board Members and Executives have a history of service to the United States of America: Maj. Gen. Leo V. Williams III, USMCR (Ret.) is the Executive Vice President of Medifast and the Chairman of the Board of Take Shape for Life, Col. Bradley T. MacDonald, USMCR (Ret.) is the Executive Chairman of the Board of Medifast, Inc. and Capt. Joseph Calderone, USNR (Ret.) is an independent director. We honor all those that currently serve our nation in the United States Armed Services as we fight this global war on terror. All Medifast Associates extend our best wishes to Gen. McCarthy and his wife Rosemary as they continue their service to our country.
Medifast (NYSE: MED) is the leading easy-to-use, clinically proven, portion-controlled weight-loss program. Medifast has been recommended by over 20,000 doctors and used by over one million customers since 1980. It is committed to enriching lives by providing innovative choices for lasting health. Medifast programs have been proven effective through studies by major university teaching hospitals. The company sells its products and programs via four unique distribution channels: 1) the web and national call centers, 2) the Take Shape For Life personal coaching division, 3) a national network of physicians, and 4) medically supervised Medifast Weight Control Centers. Medifast was founded in 1980 and is located in Owings Mills, Maryland. For more information, log onto http://www.choosemedifast.com.
Please Note: This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as "intend" or other similar words or the negative of such terminology. Similarly, descriptions of Medifast's objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Medifast believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, Medifast's inability to attract and retain independent Associates and Members, stability in the pricing of print, TV and Direct Mail marketing initiatives affecting the cost to acquire customers, increases in competition, litigation, regulatory changes, and its planned growth into new domestic and international markets and new channels of distribution. Although Medifast's believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.
Contact: Brendan Connors 410-504-8178 firstname.lastname@example.org
|SOURCE Medifast, Inc.|
Copyright©2009 PR Newswire.
All rights reserved